Sanofi Consumer Healthcare India informs about change in senior management

10 Oct 2025 Evaluate

In accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), Sanofi Consumer Healthcare India has informed that, Mr. Narahari Naidu, Chief Financial Officer, has resigned to explore new opportunities outside the organization. His resignation will be effective from the end of business hours of 15th October 2025, which shall be his last working day with the Company. A copy of his resignation email is enclosed. Further, the information required in terms of Regulation 30 read with Schedule III - Para A (7) of Part A of the SEBI Listing Regulations and SEBI Master Circular bearing Ref. No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November 2024 is enclosed as ‘Annexure-I’ to this letter. The Company has received the information at 11:54 am on 10th October 2025. 

The above information is a part of company’s filings submitted to BSE.

Sanofi Cons. Health Share Price

4651.00 -19.00 (-0.41%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×